Department of Orthopaedics, Yueyang Central Hospital, Yueyang, People's Repulic of China.
Department of Business English, School of Foreign Languages, Wuhan Business University, Wuhan, People's Repulic of China.
J Orthop Surg (Hong Kong). 2024 Sep-Dec;32(3):10225536241295483. doi: 10.1177/10225536241295483.
This study investigates the effectiveness of tibia periosteum distraction (TPD) applied to the tibial periosteum, an innovative approach grounded in Ilizarov's tension-stress theory, for the treatment of ischemic diabetic foot and vasculitic foot conditions.
A retrospective analysis was conducted on 33 patients (36 limbs) who underwent TPD between June 2019 and May 2022. The study comprised 21 males (23 limbs) and 12 females (13 limbs), aged 41 to 80 years (mean age: 63.4 years). Diabetic foot accounted for 27 cases, thromboangiitis obliterans for 2 cases, and arterial occlusive disease for 4 cases. The distribution of affected limbs included 15 left feet and 21 right feet. Periosteum traction commenced on the third postoperative day at a rate of approximately 0.75 mm/day, adjusted biweekly. The traction device was removed after two weeks. Evaluation included capillary refill and wound healing assessment, along with pre- and postoperative analysis of foot skin temperature, ankle-brachial index (ABI), visual analogue scale (VAS) pain scores, and peripheral blood oxygen saturation. CT angiography (CTA) was utilized to assess vascular conditions in both lower limbs.
All 33 patients were successfully followed up for a duration ranging from 4 to 24 weeks (mean: 11.03 weeks). VAS pain scores significantly decreased from preoperative (5.09 ± 1.70, range: 2-8) to postoperative two weeks (2.24 ± 0.90, range: 1-4) (t = 9.44, < .001). Oxygen saturation levels increased from 83.88% ± 11.82% (range: 58%-97%) preoperatively to 91.36% ± 5.69% (range: 76%-98%) at two weeks postoperatively (t = -4.21, < .001). Foot skin temperature also showed a significant increase (t = -3.98, < .001). Capillary refill test at two weeks postoperatively demonstrated notable improvement. CTA revealed evident neovascularization in the operated limbs compared to preoperative conditions. Wound improvement was significant in all 33 patients within two months postoperatively.
TPD emerges as a promising technique for chronic ischemic lower limb diseases, demonstrating favorable preliminary outcomes in wound healing promotion and amputation rate reduction. Nevertheless, large-scale randomized controlled trials are essential to further validate its efficacy.
本研究探讨了胫骨骨膜牵张术(TPD)应用于胫骨骨膜的有效性,这是一种基于伊利扎罗夫张应力理论的创新方法,用于治疗缺血性糖尿病足和血管炎性足病。
对 2019 年 6 月至 2022 年 5 月期间接受 TPD 的 33 例患者(36 肢)进行回顾性分析。研究包括 21 例男性(23 肢)和 12 例女性(13 肢),年龄 41 至 80 岁(平均年龄:63.4 岁)。糖尿病足 27 例,血栓闭塞性脉管炎 2 例,动脉闭塞性疾病 4 例。受累肢体分布为左侧 15 肢,右侧 21 肢。术后第 3 天开始以约 0.75 毫米/天的速度进行骨膜牵引,每两周调整一次。两周后拆除牵引器。评估包括毛细血管再充盈和伤口愈合评估,以及术前和术后足部皮肤温度、踝肱指数(ABI)、视觉模拟评分(VAS)疼痛评分和外周血氧饱和度的分析。下肢 CT 血管造影(CTA)用于评估下肢血管状况。
所有 33 例患者均成功随访 4 至 24 周(平均:11.03 周)。VAS 疼痛评分从术前的 5.09 ± 1.70(范围:2-8)显著降低至术后两周的 2.24 ± 0.90(范围:1-4)(t = 9.44,<.001)。氧饱和度从术前的 83.88% ± 11.82%(范围:58%-97%)增加到术后两周的 91.36% ± 5.69%(范围:76%-98%)(t = -4.21,<.001)。足部皮肤温度也显著升高(t = -3.98,<.001)。术后两周的毛细血管再充盈试验显示明显改善。CTA 显示与术前相比,手术肢体有明显的新生血管形成。所有 33 例患者在术后两个月内伤口均有明显改善。
TPD 作为一种治疗慢性缺血性下肢疾病的有前途的技术,在促进伤口愈合和降低截肢率方面显示出良好的初步结果。然而,需要进行大规模的随机对照试验来进一步验证其疗效。